Boston Scientific
OverviewSuggest Edit
Boston Scientific Corporation is a developer, manufacturer, and marketer of medical devices. It offers pacemakers, defibrillators, remote patient monitring and diagnostic monitoring solutions, spinal cord stimulator systems, a range of catheters, CTO systems, direct visualization systems, fiducial markers, forceps, guidewires, lasers, fibers, lifting agents, needles, penile prosthesis, retrieval devices, slings, snares, stents, ureterosopes, vein ablation solutions, thrombectomy systems, sphincterotomes, etc.
| Type | Public | |
| Founded | 1979 | |
| HQ | Marlborough, MA, US | Map |
| Website | bostonscientific.com | |
| Employee Ratings | More | |
| Overall Culture | A+ | More |
Recent NewsAll News
- Henry Schein Likely To Offer Better Returns Compared To Boston Scientific Stock
- Global $4.7 Billion Erectile Dysfunction Market Outlook and Forecast 2021-2026: Major Players are Eli Lilly and Co, VIVUS, Pfizer, Bayer, Boston Scientific, Coloplast, Teva, Viatris, Dong-A Socio
- Boston Scientific Announces February and March 2021 Conference Schedule
- Global Transcatheter Treatment: Procedures and Heart Valve Market (2020 to 2025) - Featuring Biotronik, Boston Scientific and Bracco Among Others
Key People/Management at Boston Scientific
Michael F. Mahoney
Chairman, Chief Executive Officer
Daniel J. Brennan
Executive Vice President and Chief Financial Officer
Desiree Ralls-Morrison
Senior Vice President, General Counsel and Corporate Secretary
Edward MacKey
Executive Vice President, Global Operations
Art Butcher
Executive Vice President and President, Asia Pacific
Wendy Carruthers
Senior Vice President, Human Resources
Boston Scientific Office Locations
Boston Scientific has offices in Marlborough, Arden Hills, Maple Grove, San Jose and in 22 other locations
Marlborough, MA, US (HQ)
300 Boston Scientific Way, Marlborough
Arden Hills, MN, US
4100 Hamline Ave N
Maple Grove, MN, US
1 Scimed Pl
San Jose, CA, US
150 Baytech Dr
Santa Clarita, CA, US
25155 Rye Canyon Loop, Valencia
Spencer, IN, US
780 Brookside Dr
Boston Scientific Financials and Metrics
Boston Scientific Revenue
Boston Scientific's revenue was reported to be $10.74 b in FY, 2019 which is a 9.3% increase from the previous period.
| USD | |
|---|---|
Revenue (Q3, 2020) | 2.7b |
Gross profit (Q3, 2020) | 1.8b |
Gross profit margin (Q3, 2020), % | 67.3% |
Net income (Q3, 2020) | (155.0m) |
EBIT (Q3, 2020) | (205.0m) |
Market capitalization (1-Mar-2021) | 55.1b |
Closing stock price (1-Mar-2021) | 38.9 |
Cash (30-Sept-2020) | 2.0b |
EV | 62.4b |
Boston Scientific's current market capitalization is $55.1 b.
Annual
Annual
Annual
Quarterly
| USD | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
|---|---|---|---|---|---|---|---|---|---|
Net Income | 298.0m | 853.0m | 1.3b | 424.0m | 578.0m | 704.0m | 11.0m | ||
Cash From Operating Activities | 193.0m | (210.0m) | 291.0m | 350.0m | 642.0m | 1.1b | (77.0m) | 192.0m | 835.0m |
Purchases of PP&E | (60.0m) | (134.0m) | (210.0m) | (63.0m) | (154.0m) | (275.0m) | (100.0m) | (168.0m) | (217.0m) |
Cash From Investing Activities | (173.0m) | (664.0m) | (1.3b) | (410.0m) | (1.0b) | (5.0b) | (76.0m) | (135.0m) | (264.0m) |
| USD | FY, 2017 |
|---|---|
Revenue/Employee | 312.0k |
Debt/Equity | 0.5 x |
Debt/Assets | 0.2 x |
Financial Leverage | 2.7 x |
Boston Scientific Acquisitions / Subsidiaries
| Company Name | Date | Deal Size |
|---|---|---|
| VertiFlex | May 09, 2019 | $465 m |
| BTG | November 19, 2018 | $4.20 b |
| Augmenix | September 10, 2018 | $600 m |
| Veniti | August 08, 2018 | $160 m |
| Claret Medical | July 20, 2018 | $270 m |
| Cryterion Medical | July 05, 2018 | |
| nVision Medical | April 12, 2018 | $275 m |
| Securus Medical Group | April 03, 2018 | |
| NxThera | March 21, 2018 | $306 m |
| EMcision | March 05, 2018 |
Boston Scientific Revenue Breakdown
Boston Scientific revenue breakdown by business segment: 30.8% from MedSurg, 29.2% from Rhythm Management, 39.2% from Cardiovascular and 0.8% from Other
Boston Scientific revenue breakdown by geographic segment: 57.4% from U.S. and 42.6% from Other Countries
Boston Scientific Cybersecurity Score
Boston Scientific Environment, Social & Governance (ESG) Ratings
Boston Scientific Online and Social Media Presence
34.18k Twitter followers
Boston Scientific has 34.18k Twitter Followers. The number of followers has increased 1.2% month over month and increased 2.6% quarter over quarter
Boston Scientific's Trends
Twitter Engagement Stats for @bostonsci
2.4k
Tweets
175
Following
34.2k
Followers
26
Tweets last 30 days
14.7
Avg. likes per Tweet
84.6%
Tweets with engagement
Boston Scientific Company Culture
Overall Culture
A+
78/100
CEO Rating
A+
87/100
Compensation
A+
83/100
Diversity
B+
74/100
Boston Scientific News and Updates
February 24, 2021
Henry Schein Likely To Offer Better Returns Compared To Boston Scientific Stock
We think that Henry Schein currently is a better pick compared to Boston Scientific. HSIC stock trades at about 0.9x trailing Revenues, compared to around 5.5x for Boston Scientific. Does this gap in Henry Schein valuation make sense? While Boston Scientific’s business has been impacted in 2020...
February 23, 2021
Global $4.7 Billion Erectile Dysfunction Market Outlook and Forecast 2021-2026: Major Players are Eli Lilly and Co, VIVUS, Pfizer, Bayer, Boston Scientific, Coloplast, Teva, Viatris, Dong-A Socio
Dublin, Feb. 23, 2021 (GLOBE NEWSWIRE) -- The "Erectile Dysfunction Market - Global Outlook and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global erectile dysfunction is expected to cross $4.7 billion during the period 2021-2026.The global erectile dysfunct…
February 12, 2021
Boston Scientific Announces February and March 2021 Conference Schedule
MARLBOROUGH, Mass., Feb. 12, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences. On February 25, 2021, Dan Brennan, executive vice president and chief financial officer, and Susie Lisa, vice president, Investor Relations,...
February 11, 2021
Global Transcatheter Treatment: Procedures and Heart Valve Market (2020 to 2025) - Featuring Biotronik, Boston Scientific and Bracco Among Others
Dublin, Feb. 11, 2021 (GLOBE NEWSWIRE) -- The "Transcatheter Treatment: Procedures and Heart Valve Market" report has been added to ResearchAndMarkets.com's offering.
February 03, 2021
Stocks making the biggest moves in the premarket: Spotify, Boston Scientific, Alphabet & more
Names on the move ahead of the open.
February 03, 2021
Boston Scientific stock falls after profit and sales miss, downbeat outlook
Shares of Boston Scientific Corp. dropped 3.2% in premarket trading Wednesday, after the medical technology company reported fourth-quarter profit and revenue that fell more than expected, and provided a downbeat first-quarter outlook. Net income fell to $138 million, or 10 cents a share, from $4.0…
Boston Scientific Blogs
January 14, 2021
Boston Scientific Launches WaveWriter Alpha™ Spinal Cord Stimulator Systems In U.S.
SCS portfolio features largest portfolio of full-body MRI conditional devices that combine therapy options for personalized pain relief
November 05, 2020
Boston Scientific Announces November 2020 Conference Schedule
November 02, 2020
Boston Scientific Receives FDA Approval for the Ranger™ Drug-Coated Balloon
Company provides physicians with first portfolio comprised of drug-eluting stent and drug-coated balloon for the treatment of patients with peripheral artery disease
October 29, 2020
Boston Scientific Initiates Trial to Evaluate WATCHMAN FLX™ Left Atrial Appendage Closure Device as First-Line Treatment for People at Risk of Stroke
Trial to study next-generation device as treatment alternative to NOACs for broader population of patients with non-valvular atrial fibrillation
September 30, 2020
Boston Scientific Launches WaveWriter Alpha™ Spinal Cord Stimulator Systems In Europe
SCS portfolio features full-body MRI conditional devices that combine therapy options for personalized pain relief
Boston Scientific Frequently Asked Questions
When was Boston Scientific founded?
Boston Scientific was founded in 1979.
Who are Boston Scientific key executives?
Boston Scientific's key executives are Michael F. Mahoney, Daniel J. Brennan and Desiree Ralls-Morrison.
How many employees does Boston Scientific have?
Boston Scientific has 36,000 employees.
What is Boston Scientific revenue?
Latest Boston Scientific annual revenue is $10.7 b.
What is Boston Scientific revenue per employee?
Latest Boston Scientific revenue per employee is $298.2 k.
Who are Boston Scientific competitors?
Competitors of Boston Scientific include Merit Medical Systems, Integer Holdings and Johnson & Johnson.
Where is Boston Scientific headquarters?
Boston Scientific headquarters is located at 300 Boston Scientific Way, Marlborough, Marlborough.
Where are Boston Scientific offices?
Boston Scientific has offices in Marlborough, Arden Hills, Maple Grove, San Jose and in 22 other locations.
How many offices does Boston Scientific have?
Boston Scientific has 28 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies